Use of rituximab to decrease panel-reactive antibodies. Export

@article{citeulike:1712303, abstract = {Patients with pre-formed antibodies may be at increased risk of rejection after organ transplantation. In this report, we describe the use of rituximab to decrease the percentage of pre-formed antibodies in a pediatric heart transplant recipient.}, address = {Division of Cardiology, Department of Pediatrics, St. Louis University Health Sciences Center, St. Louis, Missouri 63104, USA. balfoui@slu.edu}, author = {Balfour, I. C. and Fiore, A. and Graff, R. J. and Knutsen, A. P.}, citeulike-article-id = {1712303}, citeulike-linkout-0 = {http://dx.doi.org/10.1016/j.healun.2004.01.006}, citeulike-linkout-1 = {http://view.ncbi.nlm.nih.gov/pubmed/15896765}, citeulike-linkout-2 = {http://www.hubmed.org/display.cgi?uids=15896765}, doi = {10.1016/j.healun.2004.01.006}, issn = {1053-2498}, journal = {J Heart Lung Transplant}, keywords = {amr, hla, sensitized, transplantation}, month = {May}, number = {5}, pages = {628--630}, posted-at = {2007-09-30 21:37:07}, priority = {2}, title = {Use of rituximab to decrease panel-reactive antibodies.}, url = {http://dx.doi.org/10.1016/j.healun.2004.01.006}, volume = {24}, year = {2005} }

TY - JOUR ID - citeulike:1712303 L3 - citeulike-article-id:1712303 N2 - Patients with pre-formed antibodies may be at increased risk of rejection after organ transplantation. In this report, we describe the use of rituximab to decrease the percentage of pre-formed antibodies in a pediatric heart transplant recipient. IS - 5 JF - J Heart Lung Transplant SN - 1053-2498 AD - Division of Cardiology, Department of Pediatrics, St. Louis University Health Sciences Center, St. Louis, Missouri 63104, USA. balfoui@slu.edu EP - 630 TI - Use of rituximab to decrease panel-reactive antibodies. VL - 24 SP - 628 KW - amr KW - hla KW - sensitized KW - transplantation AU - Balfour, IC AU - Fiore, A AU - Graff, RJ AU - Knutsen, AP PY - 2005/05// UR - http://dx.doi.org/10.1016/j.healun.2004.01.006 ER -